Merck & Co Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Excellent. Listen, let's try it again. I think we have Frank. We're going to jump right into it. Frank, let me turn it over to you for some opening comments, and we'll dig right in.
Sure, Umer. I'll be very brief. I just want to thank everyone for joining. We have a lot of excitement happening at Merck right now. We had a very strong quarter that we announced, both top and bottom line, good operational performance, Umer, good performance throughout the year. A lot of strategic actions that have taken place, the spin of Organon this year. We've announced the closing now of our Acceleron business development transaction.
And we're really excited to be a new, agile, focused management team. Obviously, we had an important AdCom yesterday, I'm sure we'll get into. And also this morning, we announced VAXNEUVANCE as an accelerated approval opportunity for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
